Skip to main content
Equibles

MORGAN STANLEY

Position in IGC — IGC Pharma, Inc.

CIK 895421 NEW YORK, NY
Back to IGC Full portfolio

Position in IGC

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$9,502
+$372 QoQ
Shares Held
35,198
+0.2% QoQ
Ownership
0.034%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in IGC Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MORGAN STANLEY holds $16,838,661,229 across 524 Biotechnology names. IGC ranks #425 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RPRX
Royalty Pharma plc
 42,931,597 $2,407,174,637
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,242,139 $1,610,467,694
3 ROIV
Roivant Sciences Ltd.
 42,592,905 $1,507,362,901
4 REGN
Regeneron Pharmaceuticals, Inc.
 1,397,712 $871,529,332
5 MRNA
Moderna, Inc.
 9,538,094 $667,952,718
6 ARGX
Argenx SE
 643,123 $596,670,219
7 TECH
BIO-TECHNE Corp
 6,374,717 $450,373,747
8 INCY
Incyte Corp
 2,948,364 $334,226,536

All Filings in IGC

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $9,502 35,198
2026-03-31 $9,130 35,118
2025-12-31 $4,957 17,707
2025-09-30 $7,436 17,707
2025-06-30 $5,489 17,707
2025-03-31 $4,957 17,707
2024-12-31 $6,020 17,707
2024-09-30 $7,635 17,757
2024-06-30 $369 860
2024-03-31 $344 860
2023-12-31 $240 860
2023-09-30 $291 810
2023-06-30 $251 810
2023-03-31 $275 810
2022-12-31 $259 810
2022-09-30 $391 910
2022-06-30 $747 1,411
2022-03-31 $1,376 1,449
2021-12-31 $1,381 1,410
2021-09-30 $2,086 1,410
2021-06-30 $820 500
2021-03-31 $895 500
2020-12-31 $2,343 1,502
2020-09-30 $4,940 4,750
2020-06-30 $2,250 3,750
2020-03-31 $1,225 2,500